KPIs & Operating Metrics(New)

Gsk (GSK) Payables (2009 - 2026)

Gsk (GSK) posted Payables of $24.4 billion for Q4 2025, up 7.72% on a QoQ basis from $22.7 billion in Q4 2024, and up 7.72% year-over-year from $22.7 billion in Q4 2024.

Gsk (GSK) has 10 years of Payables data on file, last reported at $24.4 billion in Q4 2025.

  • In Q4 2025, Payables rose 7.72% year-over-year to $24.4 billion; the TTM figure through Dec 2025 stood at $24.4 billion (up 7.72% YoY), while the FY2025 annual figure was $24.4 billion, up 7.72% from the prior year.
  • Payables climbed to $24.4 billion in Q4 2025, from $22.7 billion in the prior quarter.
  • Across five years, Payables topped out at $28.5 billion in Q4 2021 and bottomed at $22.7 billion in Q4 2024.
  • A 5-year average of $24.5 billion and a median of $23.7 billion in 2022 frame the typical range for Payables.
  • Annual changes were most pronounced in 2021 — Payables rose 10.38% — and 2022, when it dropped 16.85%.
  • Year by year, Payables stood at $28.5 billion in 2021, then decreased by 16.85% to $23.7 billion in 2022, then decreased by 2.34% to $23.2 billion in 2023, then slipped by 1.98% to $22.7 billion in 2024, then rose by 7.72% to $24.4 billion in 2025.
  • The last three Payables figures came in at $24.4 billion (Q4 2025), $22.7 billion (Q4 2024), and $23.2 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 5.03 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 27.92 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 33.77 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 6.01 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 2.94 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 645.00 Mn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 4.51 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 4.23 Bn
10 Gsk 88.34 Bn 83.66 Bn - 24.45 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -19.65 Bn
Dec 31, 2025 -24.47 Bn
Sep 30, 2025 -25.01 Bn
Jun 30, 2025 -22.51 Bn
Mar 31, 2025 -19.35 Bn
Dec 31, 2024 22.70 Bn
Sep 30, 2024 -18.89 Bn
Jun 30, 2024 -22.23 Bn
Mar 31, 2024 -18.80 Bn
Dec 31, 2023 23.16 Bn
Sep 30, 2023 -19.94 Bn
Jun 30, 2023 -24.87 Bn
Mar 31, 2023 -17.55 Bn
Dec 31, 2022 23.71 Bn
Sep 30, 2022 -19.29 Bn
Jun 30, 2022 -22.84 Bn
Mar 31, 2022 -4.51 Bn
Dec 31, 2021 28.52 Bn
Sep 30, 2021 -21.35 Bn
Jun 30, 2021 -26.99 Bn
Mar 31, 2021 -21.01 Bn
Dec 31, 2020 25.83 Bn
Sep 28, 2020 -622.90 Mn
Jun 30, 2020 -26.59 Bn
Mar 31, 2020 -20.30 Bn
Dec 31, 2019 28.10 Bn
Sep 30, 2019 -28.31 Bn
Jun 30, 2019 -30.27 Bn
Mar 31, 2019 -17.74 Bn
Dec 31, 2018 25.52 Bn
Sep 30, 2018 -17.33 Bn
Jun 30, 2018 -21.82 Bn
Mar 31, 2018 -29.68 Bn
Dec 31, 2017 8.43 Bn
Sep 30, 2017 -32.16 Bn
Jun 30, 2017 -33.47 Bn
Mar 31, 2017 -15.47 Bn
Dec 31, 2016 20.01 Bn
Sep 30, 2016 -16.04 Bn
Jun 30, 2016 -21.41 Bn
Mar 31, 2016 -16.58 Bn
Dec 31, 2015 -15.47 Bn
Sep 30, 2015 -15.75 Bn
Jun 30, 2015 -16.84 Bn
Mar 31, 2015 -13.72 Bn
Dec 31, 2014 -17.27 Bn
Sep 30, 2014 -13.12 Bn
Jun 30, 2014 -16.98 Bn
Mar 31, 2014 -12.55 Bn
Dec 31, 2013 -17.98 Bn
Sep 30, 2013 -16.35 Bn
Jun 30, 2013 -15.62 Bn
Mar 31, 2013 -12.46 Bn
Dec 31, 2012 754.76 Mn
Sep 30, 2012 -12.31 Bn
Jun 30, 2012 -17.13 Bn
Mar 31, 2012 -15.37 Bn
Dec 31, 2011 594.05 Mn
Sep 30, 2011 -12.96 Bn
Jun 30, 2011 -13.54 Bn
Mar 31, 2011 -12.02 Bn
Dec 31, 2010 -11.28 Bn
Sep 30, 2010 -11.08 Bn
Jun 30, 2010 -10.48 Bn
Mar 31, 2010 -12.22 Bn
Dec 31, 2009 -13.46 Bn
Sep 30, 2009 -10.55 Bn
Jun 30, 2009 -9.83 Bn
Mar 31, 2009 -8.76 Bn